KRAS mutations in advanced nonsquamous non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy have no predictive value

Wouter W Mellema, Anne-Marie C Dingemans, Erik Thunnissen, Peter J F Snijders, Jules Derks, Daniëlle A M Heideman, Robertjan Van Suylen, Egbert F Smit*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

35 Citations (Scopus)
1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'KRAS mutations in advanced nonsquamous non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy have no predictive value'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases